Rheumatologic Disorders

Disease State Hub

Polls

Poll

Screening for Depression, Anxiety in Patients With Psoriatic Arthritis

04/09/2024

According to the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), mood disorders are a key comorbidity in patients with psoriatic arthritis. How often do you screen for...

04/09/2024

poll

Gout and Nonadherence to Therapy

01/29/2024

What do you observe as the main reason for nonadherence to urate-lowering therapy among your patients? Let us know by taking this quick poll!

01/29/2024

Rheumatologic disorders

Poll: AS and Psychological Health

12/14/2018

Take our poll on the rheumatologist’s role in determining whether a patient with ankylosing spondylitis is emotionally and psychologically healthy.

12/14/2018

Rheumatologic disorders

Poll: TNF-α inhibitors in AS

10/26/2018

Rheumatologic disorders

Poll: What’s the Diagnosis?

10/05/2018

Take our poll on a case of limping in a 5-year-old boy to determine the diagnosis.

10/05/2018

Research Summaries

Conference Coverage

Updates in the Treatment, Management of Osteoporosis and Osteopenia

07/24/2024

Jessica Ganga

Robert Wermers, MD, and Monica Richey, MSN, ANP-bc, provide management updates and guidelines for clinicians who are treating patients with osteoporosis and osteopenia in their session at the Practical...

07/24/2024

Research Summary

Global Disease Burden of Osteoarthritis Across Two Decades and Future Projections

01/10/2024

Jessica Ganga

Osteoarthritis is a common chronic and degenerative disease among adults. A group of experts estimated the disease’s burden spanning two decades and the projection of burden to 2050.

01/10/2024

FDA ALERT

FDA Approves First Biosimilar to Tocilizumab to Treat Adults, Pediatric Patients With Arthritis

11/15/2023

Jessica Ganga

In late September, the FDA approved the first biosimilar to tocilizumab to treat adult and pediatric patients with various indications of arthritis.

11/15/2023

research summary

research summary

Drug Survival, Effectiveness of IL-23 Inhibitors for Psoriasis, PsA

10/26/2023

Leigh Precopio

Despite being approved for use, consensus among the real-world data on the use of IL-23 inhibitors in psoriatic disease has been lacking; therefore, researchers recently examined the drug survival and...

10/26/2023

research summary

research summary

Efficacy, Safety of Risankizumab for Treatment of Active Psoriatic Arthritis

06/21/2023

Leigh Precopio

Researchers examined the efficacy and safety of a humanized monoclonal antibody for the treatment of active psoriatic arthritis in some patient populations.

06/21/2023

October 2024

Current Issue

October 2024

Volume 64

Issue 9